La bourse est fermée

Danaher Corporation (DHR)

NYSE - Nasdaq Cours en temps réel. Devise en USD
Ajouter à la liste dynamique
254,89-3,82 (-1,48 %)
À partir de 11:32AM EDT. Marché ouvert.

Danaher Corporation

2200 Pennsylvania Avenue, North West
Suite 800 West
Washington, DC 20037-1701
United States
202 828 0850
https://www.danaher.com

Secteur(s)Healthcare
Secteur d’activitéDiagnostics & Research
Employés à temps plein61 000

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Steven M. RalesCo-Founder & ChairmanS.O.S.O.1951
Mr. Rainer M. BlairPresident, CEO & Director5,33MS.O.1964
Mr. Mitchell P. RalesCo-Founder & DirectorS.O.S.O.1957
Mr. Matthew R. McGrewCFO & Executive VP2,56MS.O.1972
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.Senior VP & Chief Science Officer2,09MS.O.1962
Ms. Georgeann F. CoucharaSenior Vice President of Human Resources1,66MS.O.1977
Mr. Joakim WeidemanisExecutive Vice President2,76M6,5M1969
Mr. Christopher M. BoudaVP & Chief Accounting OfficerS.O.S.O.S.O.
Mr. John BedfordVice President of Investor RelationsS.O.S.O.S.O.
Mr. Brian W. EllisSenior VP, General Counsel & Chief Compliance Officer1,93MS.O.1967
Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Danaher Corporation en date du 1 mai 2024 est 7. Les scores principaux sont Audit : 9; Société : 10; Droits des actionnaires : 2; Compensation : 1.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.